logo

For the Inventor, By the Inventor

Largo, FL, United States of America

Roland Douglas Shytle

This inventor holds 17 USPTO granted patents and 7 published patent applications and 2 EPO patents, primarily in Lithium-Ion Chemistry. Top assignees: University of South Florida, Natura Therapeutics, Inc., Targacept, Inc.. Active years: 2000-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland Douglas Shytle. Retrieved from https://idiyas.com/inventor/roland-douglas-shytle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 70.6

 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 83(Granted Patents)


Location History:

  • Lutz, FL (US) (2000 - 2005)
  • Largo, FL (US) (2014 - 2022)

Company Filing History:

goldMedal15 out of 1,993 
 
University of South Florida
 patents
silverMedal2 out of 3 
 
Natura Therapeutics, Inc.
 patents
bronzeMedal1 out of 91 
 
Targacept, Inc.
 patents
4. 1 out of 960 
 
The United States Government as Represented by the Department of Veterans Affairs
 patents
5. 1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Lithium Ionic Compounds
Cocrystal Compositions
Nutraceuticals
Cognitive Performance
Alzheimer's Treatment
Neuropsychiatric Disorders
Fragile X Syndrome
Bioavailability Improvement
STAT3 Inhibitors
Organic Anions
Cognitive Deficits
Nicotinic Antagonists
17 patents (USPTO):Explore Patents
1. 12286445 - Organic anion lithium ionic cocrystal compounds and compositions (2025-04-29),
2. 11459341 - Organic anion lithium ionic cocrystal compounds and compositions (2022-10-04),
3. 10870665 - Organic anion lithium ionic cocrystal compounds and compositions (2020-12-22),
4. 10842797 - Nutraceutical co-crystal compositions (2020-11-24),
5. 10828312 - Lithium cholesterol compositions, including, but not limited to lithium cholesterol sulfate compositions, and methods of treatment for Alzheimer's disease and neurological disorders (2020-11-10),
6. 10435416 - Organic anion lithium ionic cocrystal compounds and compositions (2019-10-08),
7. 10376521 - Nutraceutical co-crystal compositions (2019-08-13),
8. 10130708 - Lithium cocrystal compositions (2018-11-20),
9. 10098909 - Ionic cocrystal of lithium, lispro, for the treatment of fragile X syndrome (2018-10-16),
10. 9840521 - Organic anion lithium ionic cocrystal compounds and compositions (2017-12-12),
11. 9827285 - Compositions and methods of improving cognitive performance (2017-11-28),
12. 9603869 - Lithium co-crystals and an additional neuropsychiatric agent for treatment of neuropsychiatric disorders (2017-03-28),
13. 9180191 - Treatment of suicidal ideation or behavior using inhibitors of nicotinic acetylcholine receptors (2015-11-10),
14. 8906414 - Methods and compositions for improving bioavailability of epigallocatechin gallate (EGCG) (2014-12-09),
15. 8778894 - Luteolin and diosmin/diosmetin as novel STAT3 inhibitors for treating autism (2014-07-15),

Title: The Innovative Contributions of Roland Douglas Shytle

Introduction

Roland Douglas Shytle is a notable inventor based in Largo, FL (US), recognized for his significant contributions to the field of pharmaceutical compositions. With a total of 17 patents to his name, Shytle has made remarkable advancements in the development of organic anion lithium ionic cocrystal compounds.

Latest Patents

Among his latest patents, Shytle has developed organic anion lithium ionic cocrystal compounds and compositions. These cocrystals have the formula LiX·aM, or a solvate or hydrate thereof, where X represents a conjugate base of an organic acid, M is a neutral organic molecule, and a ranges from 0.5 to 4. His work includes pharmaceutical compositions comprising such cocrystals, cocrystal solvates, or cocrystal hydrates, along with methods for preparing these innovative compounds.

Career Highlights

Shytle has had a distinguished career, working with esteemed institutions such as the University of South Florida and Natura Therapeutics, Inc. His research and inventions have contributed significantly to advancements in pharmaceutical sciences.

Collaborations

Shytle has collaborated with notable individuals in his field, including Adam John Smith and Jun Tan. These partnerships have further enhanced his innovative work and contributions to the industry.

Conclusion

Roland Douglas Shytle's inventive spirit and dedication to research have led to significant advancements in pharmaceutical compositions, particularly in the realm of organic anion lithium ionic cocrystal compounds. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…